Showing results (3321-3330 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|February 1, 2021
Cancer of Unknown Primary Presenting as Bone-Predominant or Lymph Node-Only Disease: A Clinicopathologic PortraitRyan W Huey, Brandon G Smaglo, Jeannelyn S Estrella, et al.
The Oncologist|September 14, 2019
Impact of Older Age and Comorbidity on Locoregional and Distant Breast Cancer Recurrence: A Large Population-Based StudyAnna Z de Boer, Heleen C van der Hulst, Nienke A de Glas, et al.
The Oncologist|August 29, 2019
Capecitabine and Temozolomide in Advanced Lung Neuroendocrine NeoplasmsTaymeyah Al-Toubah, Brian Morse, Jonathan Strosberg
The Oncologist|January 18, 2021
Can Some Anticancer Treatments Preserve the Ovarian Reserve?Nicolas Vallet, Nicolas Boissel, Elisabeth Elefant, et al.
The Oncologist|January 18, 2021
First-in-Class Selective HDAC6 Inhibitor (ACY-1215) Has a Highly Favorable Safety Profile in Patients with Relapsed and Refractory LymphomaJennifer E Amengual, Jennifer K Lue, Helen Ma, et al.
The Oncologist|February 24, 2019
Minimally Invasive Cordotomy for Refractory Cancer Pain: A Randomized Controlled TrialAshwin Viswanathan, Aditya Vedantam, Kenneth R Hess, et al.
The Oncologist|February 24, 2019
A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell CarcinomaBhumsuk Keam, Keun-Wook Lee, Se-Hoon Lee, et al.
The Oncologist|March 2, 2019
Immuno-Oncology in ChinaShun Lu, Bruce A Chabner
The Oncologist|March 2, 2019
Retrospect and Prospect for Lung Cancer in China: Clinical Advances of Immune Checkpoint InhibitorsShun Lu, Yongfeng Yu, Yi Yang
The Oncologist|March 2, 2019
PD-1/PD-L1 Blockade Therapy in Advanced Non-Small-Cell Lung Cancer: Current Status and Future DirectionsLiliang Xia, Yuanyong Liu, Ying Wang
Pageof 571